Objective: To determine the frequency and type of epidermal growth factor receptor( EGFR) exon 18,19,21 exon mutations in cytology and blood specimens from lung carcinomas. To explore the relationship of EGFR mutation from cytology versus histology specimes. Methods: All 53 cytology specimens and 24 blood specimens were collected from patients with lung cancer. The tissue DNA was abstracted and the exons 18,19,21 in EGFR gene were subjected for PCR amplification and direct sequencing. Results: EGFR mutation...
【更新日期】
2015-05-18
【分类号】
R734.2
【正文快照】
Modern Oncology 2015,23(09):1209-1212【修回日期】2014-11-11非小细胞肺癌的表皮生长因子受体(epidermal growthfactor receptor,EGFR)基因突变是决定是否使用酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)靶向药物治疗的重要因素,肿瘤细胞EGFR基因突变的检测结果也成